Opening up the Ivory Tower.
Big pharma is increasingly looking to academia for new drug leads and technologies; meanwhile universities are being forced to look beyond the National Institutes of Health (NIH) for funding. This mutual attraction-out-of-necessity is helping to forge new bonds between industry and academia.
Wilan
Ken Howard
KH
D004345:Drug Industry / Q000639:trends*; D009316:National Institutes of Health (U.S.); D010330:Patents as Topic; D012109:Research Support as Topic; D014481:United States; D014495:Universities / Q000191:economics* / Q000639:trends